Pharmachim SRL
2.8 FTEThe score of Pharmachim shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +131 % Total assets +18 % Headcount (avg FTE) +22 %
Accounts of the company itself (not consolidated).
The full file covers 14 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmachim's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 53,894 € | ||||
| Equity | 295,335 € | ||||
| Cash | 129,530 € | ||||
| EBITDA | 111,894 € | ||||
| Total assets | 797,111 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Aug 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 24 Jun 2022
Pharmachim's financial analysis
- Solvency37.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmachim
Pharmachim's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0467.190.503
- VAT number
- BE0467190503
- Peppol
- Registered · 0208:0467190503 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Dec 1999
- Registered office
- 4101 Seraing
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2025 · filed on 20 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmachim (SRL) has been based in Seraing since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 53,894 € and equity of 295,335 €; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 37.1%, below the median of its sector (41.5%).
Companies similar to Pharmachim
Companies in the same business, of comparable size and area, outside its group.
- GS Pharma Retail sale of pharmaceutical products Dilbeek · balance sheet 796,930 €
- Pharmacie Goffin Gray Retail sale of pharmaceutical products Etterbeek · balance sheet 798,770 €
- Apotheek Schelfhout Retail sale of pharmaceutical products Evergem · balance sheet 798,974 €
- Cobra Apotheek Centrum Retail sale of pharmaceutical products Mol · balance sheet 791,276 €
- Gooreind Pharma Retail sale of pharmaceutical products Wuustwezel · balance sheet 791,241 €
- Paal Farma Retail sale of pharmaceutical products Beringen · balance sheet 790,795 €
- Dr. Apr. D. Kieffer Retail sale of pharmaceutical products Hasselt · balance sheet 790,139 €
- Zoniapharma Retail sale of pharmaceutical products Sint-Genesius-Rode · balance sheet 804,389 €
Frequently asked questions about Pharmachim
What is the revenue of Pharmachim?
Pharmachim files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmachim?
In Belgium, the VAT number is the company number prefixed with BE: BE0467190503 for Pharmachim, if the company is VAT-registered. Its company number (CBE) is 0467.190.503.
Where is the registered office of Pharmachim?
According to the CBE register, the registered office of Pharmachim is in 4101 Seraing.
What is the equity of Pharmachim?
At the close of the 2025 financial year, the equity of Pharmachim amounts to 295,335 €, a solvency of 37.1% of total assets.
How many people work at Pharmachim?
2.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmachim?
The register lists 1 active mandates at Pharmachim. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmachim
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →